ReviewCurrent opinion in gastroenterology2015

Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma.

Mitesh J Borad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.